Clinical Trial

DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombosis

Study acronym: DEFIANCE
Recruiting
View on ClinicalTrials.gov →
Summary
This study is a prospective, multicenter, randomized controlled trial of an interventional strategy using the ClotTriever System to achieve and maintain vessel patency (ClotTriever Intervention Arm) versus conservative medical management using anticoagulation therapy alone (Conservative Medical Management Arm) in the treatment of subjects with symptomatic unilateral iliofemoral DVT. The study will collect data on demographics, comorbidities, details from the DVT diagnosis and treatment, and clinical outcomes through the 6-month follow up visit.
Protocol Amendment History 2 changes
notable Primary completion pushed: 2026-06-30 -> 2028-01-31 2026-07-24
minor Completion pushed: 2027-01-15 -> 2028-07-31 2026-07-24
Trial Details
NCT Number NCT05701917
Lead Sponsor Inari Medical
Conditions Venous Thromboembolism, Deep Venous Thrombosis, Post-Thrombotic Syndrome
Enrollment 300 participants
Start Date 2023-01-06
Primary Completion 2028-01-31 (estimated)
Study Completion 2028-07-31 (estimated)
Updated on ClinicalTrials.gov 2026-07-23